Jiangxi Tengwangge Pharmaceutical Co., Ltd., commonly referred to as Tengwangge, is a prominent player in the pharmaceutical industry, headquartered in Jiangxi, China. Established in 2001, the company has made significant strides in the development and production of high-quality pharmaceutical products, focusing on both traditional Chinese medicine and modern pharmaceuticals. With a strong operational presence across various regions in China, Tengwangge is renowned for its innovative formulations and commitment to research and development. The company’s core offerings include a diverse range of prescription medications and over-the-counter products, distinguished by their efficacy and adherence to stringent quality standards. Tengwangge has positioned itself as a leader in the market, achieving notable milestones in product development and regulatory compliance, which underscore its dedication to improving healthcare outcomes.
How does Jiangxi Tengwangge Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Jiangxi Tengwangge Pharmaceutical Co., Ltd.'s score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jiangxi Tengwangge Pharmaceutical Co., Ltd., headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. It is important to note that Jiangxi Tengwangge Pharmaceutical Co., Ltd. is a current subsidiary and may inherit emissions data and climate initiatives from its parent or related organisations. However, no specific cascading data or initiatives have been provided from the parent company or other sources. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and climate action. Jiangxi Tengwangge Pharmaceutical Co., Ltd. may benefit from aligning with industry standards and best practices to enhance its environmental performance in the future.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Jiangxi Tengwangge Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
